Buffett is not known for investing in pre revenue biotech's and I also doubt he understands MSB as well which also rules this company out for him.
Strange to mention him here accordingly. He is great at what he does in the area he does it.
Max Gunther's book The Zurich Axioms is more appropriate for this sort of investment. opportunity. However, one needs the IQ to research well and psychological guts, over time, to take proper advantage of what he says. If either attribute is lacking success is unlikely; sustainably.
banter and General Discussion, page-8286
-
- There are more pages in this discussion • 2,787 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |